A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms)

Abstract

Adults with metabolic syndrome from different race/ethnicities are often predisposed to developing type 2 diabetes (T2D); however, growing evidence suggests that healthy diets and lifestyle choices can significantly slow or prevent progression to T2D. This poorly understood relationship to healthy dietary patterns and prevention of T2D motivated us to conduct a retrospective analysis to determine the potential impact of a minor dietary lifestyle change (daily mushroom consumption) on known T2D risk factors in racially diverse adults with confirmed features of the metabolic syndrome. Retrospectively, we studied 37 subjects who had participated in a dietary intervention focused on vitamin D bioavailability from white button mushrooms (WBM). All 37 had previously completed a 16-week study where they consumed 100 g of WBM daily and were then followed-up for one month during which no mushrooms were consumed. We analyzed differences in serum risk factors from baseline to 16-week, and from baseline to one-month follow-up. Measurement of serum diabetic risk factors included inflammatory and oxidative stress markers and the antioxidant component naturally rich in mushrooms, ergothioneine. Significant beneficial health effects were observed at 16-week with the doubling of ergothioneine from baseline, increases in the antioxidant marker ORAC (oxygen radical absorption capacity) and anti-inflammatory hormone, adiponectin and significant decreases in serum oxidative stress inducing factors, carboxymethyllysine (CML) and methylglyoxal (MG), but no change in the lipid oxidative stress marker 8-isoprostane, leptin or measures of insulin resistance or glucose metabolism. We conclude that WBM contain a variety of compounds with potential anti-inflammatory and antioxidant health benefits that can occur with frequent consumption over time in adults predisposed to T2D. Well-controlled studies are needed to confirm these findings and identify the specific mushroom components beneficial to health.

This is a preview of subscription content, access via your institution.

Fig. 1

Abbreviations

AGE:

Advanced glycation end product

CVD:

Cardiovascular disease

vitamin D2 :

Ergocalciferol

25OHD:

25-hydroxyvitamin D

MG:

Methylglyoxal derivatives

CML:

Nε –carboxymethyl-lysine

ORAC:

Oxygen radical absorbance capacity

ROS:

Reactive oxygen species

OS:

Oxidative stress factors

T2D:

Type 2 diabetes

WBM:

White button mushrooms

References

  1. 1.

    Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365(9468):1415–1428. doi:10.1016/S0140-6736(09)61794-3

    CAS  Article  Google Scholar 

  2. 2.

    Ford ES, Giles WH, Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 27(10):2444–2449

    Article  Google Scholar 

  3. 3.

    Furukawa S, Fujita T, Shimabukuro M, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114(12):1752–1761

    CAS  Article  Google Scholar 

  4. 4.

    Vlassara H, Uribarri J (2014) Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep 14(1):453

    Article  Google Scholar 

  5. 5.

    Folchetti LD, Monfort-Pires M, de Barros CR, Martini LA, Ferreira SRG (2014) Association of fruits and vegetables consumption and related-vitamins with inflammatory and oxidative stress markers in pre-diabetic individuals. Diabetol Metab Syndr 6(1):22

    Article  Google Scholar 

  6. 6.

    Monfort-Pires M, Folchetti LD, Previdelli AN, Siquerira-Catania A, de Barros CR, Ferreira SRG (2014) Healthy eating index is associated with certain markers of inflammation and insulin resistance but not with lipid profile in individuals at cardio-metabolic risk. Appl Physiol Nutr Metab 39(4):497–502

    CAS  Article  Google Scholar 

  7. 7.

    Dai X, Stanilka JM, Rowe CA, Esteves EA, Nieves C jr, Spaiser SJ, Christman MC, Langkamp-Henken B, Percival SS (2015) Consuming Lentinula edodes (shitake) mushrooms daily improves human immunity: a randomized dietary intervention in healthy young adults. J Am Coll Nutr 34(6):478–487

  8. 8.

    Weigand-Heller AJ, Kris-Etherton PM, Beelman RB (2012) The bioavailability of ergothioneine from mushrooms (Agaricus bisporus) and the acute effects on antioxidant capacity and biomarkers of inflammation. Prev Med 54(Suppl):S75–S78

    CAS  Article  Google Scholar 

  9. 9.

    Gunawardena D, Bennett L, Shanmugam K, et al. (2014) Anti-inflammatory effects of five commercially available mushroom species determined in lipopolysaccharide and interferon-γ activated murine macrophages. Food Chem 148:92–96

    CAS  Article  Google Scholar 

  10. 10.

    Babu US, Balan KV, Garthoff LH, Calvo MS (2014) Vitamin D2 from UVB light exposed mushrooms modulates immune response to LPS in rats. Mol Nutr Food Res 58(2):318–328

    CAS  Article  Google Scholar 

  11. 11.

    Jeong SC, Jeong YT, Yang BK, et al. (2010) White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hyper-cholesterolemic rats. Nutr Res 30(1):49–56. doi:10.1016/j.nutres.2009.12.003

    CAS  Article  Google Scholar 

  12. 12.

    Aleixandre A, Miguel M (2008) Dietary fiber in the prevention and treatment of metabolic syndrome: a review. Crit Rev Food Sci Nutr 48(10):905–912

    Article  Google Scholar 

  13. 13.

    Neyrinck AM, Bindels LB, De Backer F, Pachikian DB, Cani PD, Delzenne NM (2009) Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. Int Immunopharmacol 9(6):767–773

    CAS  Article  Google Scholar 

  14. 14.

    Sánchez D, Quiñones M, Moulay L, Muguerza B, Miguel M, Aleixandre A (2011) Soluble fiber-enriched diets improve inflammation and oxidative stress biomarkers in Zucker fatty rats. Pharmacol Res (Italian) 64(1):31–35

    Article  Google Scholar 

  15. 15.

    Esfahani M, Movahedian A, Baranch M, Goodarzi MT (2015) Adiponectin: an adipokine with protective features against metabolic syndrome. Iran J Basic Med Sci 18:430–442

    Google Scholar 

  16. 16.

    Uribarri J, Cai W, Pyzik R, et al. (2014) Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases. Amino Acids 46(2):301–309. doi:10.1007/s00726-013-1502-4

    CAS  Article  Google Scholar 

  17. 17.

    Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AFH (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361(9353):226–228

    CAS  Article  Google Scholar 

  18. 18.

    Kozarski M, Klaus A, Jakovljevic D, et al. (2015) Antioxidants of edible mushrooms. Molecules 20:19489–19525

    CAS  Article  Google Scholar 

  19. 19.

    Mehrotra A, Calvo MS, Beelman RB, Levy E, Siuty J, Klaras MD, Uribarri J (2014) Bioavailability of vitamin D2 from enriched mushrooms in prediabetic adults: a randomized controlled trial. Eur J Clin Nutr 68(10):1154–1160. doi:10.1038/ejcn.2014.157

    CAS  Article  Google Scholar 

  20. 20.

    Hsu C-H, Liao Y-L, Lin S-C, Hwang K-C, Chou P (2007) The mushroom Agaricus blazei murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double blinded, and placebo-controlled clinical trial. J Altern Complement Med 13(1):97–102

    Article  Google Scholar 

  21. 21.

    Cai W, Gao Q-D, Zhu L, Peppa M, He C, Vlassara H (2002) Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med 8(7):337–346

    CAS  Google Scholar 

  22. 22.

    Uribarri J, Cai W, Ramdas M, et al. (2011) Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 34(7):1610–1616

    CAS  Article  Google Scholar 

  23. 23.

    Morrow JD (2005) Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 25(2):279–286

    CAS  Article  Google Scholar 

  24. 24.

    Wang L-Z, Thuya W-L, Toh DS-L, et al. (2013) Quantification of L-ergothioneine in human plasma and erythrocytes by liquid chromatography-tandem mass spectrometry. J Mass Spectrom 48(3):406–412

    Article  Google Scholar 

  25. 25.

    Dubost J, Beelman RB, Peterson D, Royse D (2006) Identification and quantification of ergothioneine in cultivated mushrooms by liquid chromatography-mass spectrometry. Int J Med Mushr 8:215–222. doi:10.1615/IntJMedMushr.v8.i3.30

  26. 26.

    Ito T, Kato M, Tsuchida H, Harada E, Niwa T, Osawa T (2011) Ergothioneine as an anti-oxidative/anti-inflammatory component in several edible mushrooms. Food Sci Technol Res 17:103–110. https://www.jstage.jst.go.jp/article/fstr/17/2/17_2_103/_article

    CAS  Article  Google Scholar 

  27. 27.

    Ramirez-Martinez A, Wesolek N, Yaden J-C, Roudot A-C (2015) Intake assessment of L-ergothioneine in some European countries and the United States. Hum Ecol Risk Assess 22(3):667–677 doi:10.1080/10807039.2015.1104241

  28. 28.

    Cheah IK, Halliwell B (2012) Ergothioneine; antioxidant potential, physiological function and role in disease. Biochim Biophys Acta 1822:784–793

    CAS  Article  Google Scholar 

  29. 29.

    Uribarri J, Cai W, Woodward M, et al. (2015) Elevated serum advanced glycation endproducts in obese indicate a risk for the metabolic syndrome: a link between healthy and unhealthy obesity? J Clin Endocrinol Metab 10:1957–1966

    Article  Google Scholar 

  30. 30.

    Soitiga S, Zinellu A, Mangoni AA, Pintus G, Attia J, Carru C, McEvoy M (2014) Clinical and biochemical correlates of serum L-ergothioneine concentrations in community-dwelling middle-aged and older adults. PLOS One 91(1):e84918. doi:10.1371/journal.pone.0084918

    Article  Google Scholar 

Download references

Acknowledgments

We wish to acknowledge the dedication and participation of our study participants who diligently adhered to the protocol for the full 20 weeks of study.

Author contributions

JU, MSC and RBB designed the research; JU and AM conducted the research; MDK, WL and GBC performed ergothioneine assays; WC performed AGE assays; AM, GN and JU analyzed data; MSC, JU wrote the manuscript; JU and MSC, had primary responsibility for final content. All authors have read and approved the final manuscript.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jaime Uribarri.

Ethics declarations

Disclaimer

The findings and conclusions presented in this paper are those of the author and do not necessarily represent the views and opinions of the U.S. Food and Drug Administration. Mention of trade names, product labels or food manufacturers does not constitute endorsement or recommendations of use by the U.S. Food and Drug Administration.

Conflict of interest

Each one and all authors declare no conflict of interest.

Financial Support

This study was made possible by funding from the Mushroom Council and the Australian Mushroom Growers Council, neither of which participated in the study design, data collection, data analysis or interpretation of results, or manuscript preparation.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Calvo, M.S., Mehrotra, A., Beelman, R.B. et al. A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms). Plant Foods Hum Nutr 71, 245–251 (2016). https://doi.org/10.1007/s11130-016-0552-7

Download citation

Keywords

  • White button mushrooms
  • Metabolic syndrome
  • Type 2 diabetes
  • Antioxidants
  • Ergothioneine
  • Advanced glycation end products
  • Adiponectin
  • Oxidative stress